SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

Pojak ($PJ) is gaining attention, particularly within the Phantom Wallet community on Solana, with many highlighting its potential for significant upside. Community members emphasize the coin's momentum and are encouraging others to buy in early, while some caution potential investors to be wary of a possible scam. The discussions suggest a focus on early adoption and potential gains within the Solana ecosystem.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending due to positive data from GenFleet's GFH375 in KRAS-G12D mutant pancreatic cancer, showing promising ORR, DCR, and safety results compared to existing treatments. The community views this as a significant derisking event for VSTM's pipeline, potentially leading to blockbuster status and attracting institutional interest. Discussions also revolve around potential buyout scenarios and upcoming catalysts, amid volatility and short-selling pressures.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community discusses its potential and future catalysts, including speculation around ETFs and real-world utility. Community members are weighing bullish outlooks against potential bearish signals, and debating whether to accumulate more or remain patient. Discussions also involve the broader crypto market and potential impacts from external factors.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is sparking mixed reactions, with some community members pointing to whale accumulation and potential for utility, while others express concerns about the coin's long-term potential and the lack of recent pumps. Conversations also mention a "Shib on Solana" alternative. Traders are monitoring for potential buying opportunities amidst market volatility and the broader performance of meme coins.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad is trending as the community rallies around the meme coin, highlighting its strong culture and potential for a significant run. Community members are actively discussing its resilience and narratives, with some noting a clothing brand associated with the coin. Investors are also comparing it to other meme coins, expressing confidence in its future performance.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending amid mixed sentiment, with some traders anticipating a potential crash driven by fear and margin calls, while others remain bullish, citing historical patterns and institutional accumulation. Community discussions revolve around identifying key support and resistance levels for potential trading opportunities. Technical analysis varies, with some predicting a bearish breakdown and others forecasting a bullish reversal, contributing to the current volatility.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to discussions around revenue expectations and the potential impact of a discount program, despite solid financial performance and a strong cash position. The community is closely watching the upcoming CHOPIN trial data and its implications for the company's growth prospects and potential buyout scenarios. Investors are also debating the impact of new trials on the company's cash reserves.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to recent price momentum and speculation about a potential crypto-related announcement, with community members pointing to its low float as a catalyst for a significant surge. Some traders are drawing comparisons to other stocks with similar setups that have experienced substantial gains. Chatter suggests possible expansion into mainland China.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending due to ongoing discussions about its CAN-2409 asset and potential partnerships, particularly following positive Phase II trial data in pancreatic cancer. The community is analyzing comparable deals, speculating on upfront payments, and assessing the likelihood of a strategic partnership for Phase III trials. Investors are also monitoring upcoming presentations at the Society for Immunotherapy of Cancers (SITC) 40th Anniversary Annual Meeting.

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Solana Co. - Ordinary Shares - Class A

Solana Co

The stock is trending due to a recent $500M funding round to launch a Solana-backed treasury, sparking debates about its potential as a public market SOL play. Community discussions revolve around whether this move is a game-changer or a potential dilution trap, with some traders eyeing a potential short squeeze amid high volatility and a tight float. Comparisons to other crypto-related stocks and the prospects of a Solana ETF are also fueling interest.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026 Revenue Guidance of $225 Million

SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026 Revenue Guidance of $225 Million SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026...

SurgePays, Inc. (SURG) Reports Q2 Loss, Lags Revenue Estimates

SurgePays, Inc. (SURG) delivered earnings and revenue surprises of -16.13% and -32.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Porch Group, Inc. (PRCH) Reports Break-Even Earnings for Q2

Porch Group (PRCH) delivered earnings and revenue surprises of +100.00% and +10.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

SurgePays, Inc. (SURG) Reports Q1 Loss, Tops Revenue Estimates

Shares of nano-cap SurgePays, Inc. (SURG) jumped on Wednesday after the telecom and fintech company issued an upbeat outlook after announcing subpar annual results.The Barlett, Tennessee-based company reported a loss of $2.39 per share and revenue of $60.88 million for the year ended Dec. 31. This compares to the year-ago earnings per share (EPS) of $1.45 and revenue of $137.14 million.&nbsp;SurgePays blamed the predicament on the end of the federally funded Affordable Connectivity Program (ACP).The ACP is a U.S. government-sponsored program administered by the Federal Communications Commission (FCC) that provides affordable internet access to low-income households. The program stopped accepting applications in the first half of 2024, with April 2024 being the last fully-funded month.Even so, the company&nbsp;was upbeat about&nbsp;its outlook. “However, strategic investments made during this transition — including AT&amp;T integration, POS growth, and the development of our MVNE platform — have built the foundation for 2025's goal to return to growth and profitability,” it said.&nbsp;Brian Cox, Chairman and CEO, said, "We built the infrastructure. Now we are scaling. With AT&amp;T integration complete and LinkUp Mobile launching nationally, SurgePays is positioned for the most aggressive revenue growth phase in our history."LinkUp Mobile is the company’s retail prepaid wireless brand.Looking ahead, the company expects&nbsp;over $200 million in revenue over the next 12 months and positive cash flow from operations before the end of 2025, following the successful integration and official launch with AT&amp;T.&nbsp;The revenue guidance for the year is markedly above the Finchat-compiled consensus of $95.11 million.&nbsp;On Stocktwits, retail sentiment toward SurgePays stock stayed ‘extremely bullish’ (100/100) and the message volume spurted to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:637/137;" src="https://news.stocktwits-cdn.com/surg_sentiment_png_b7d7d166fb.webp" alt="surg-sentiment.png" width="637" height="137"><figcaption>SURG sentiment and message volume March 26, as of 12:54 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>A bullish watcher positioned for a multi-day run and predicted a move to $3 on Thursday.<stembedurl>https://stocktwits.com/Harunkaraca/message/609306748</stembedurl>Another user attributed his bullish sentiment to the moving average convergence divergence (MACD) indicator crossing over.<stembedurl>https://stocktwits.com/BananaExpress15/message/609287406</stembedurl><a href="https://stocktwits.com/symbol/SURG">SurgePays stock</a> soared by over 54% to $2.13 on Wednesday afternoon. The stock is down about 22.5% this year. If the gains are sustained, the stock is on track to finish with the biggest one-day gain in four years.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/playtika-receives-double-upgrade-from-bofa/chJbRWxRb3l">Playtika Stock On Track To Record Biggest Single-Day Gain Ever After BofA’s Double Upgrade: Retail’s Exuberant</a>

Rising stock market chart on a trading board background.

SurgePays Stock Surges As Strong Guidance Overshadows FY24 Underperformance: Retail Anticipates Multi-Day Run  

 CEO Brian Cox said the company is positioned for the most aggressive revenue growth phase in its history.

Equity

 CEO Brian Cox said the company is positioned for the most aggressive revenue growth phase in its history.


SurgePays Appoints Allison Seyler as Vice President of Sales to Drive Growth Across Direct, Partner and Reseller Channels

SurgePays Appoints Allison Seyler as Vice President of Sales to Drive Growth Across Direct, Partner and Reseller Channels SurgePays Appoints Allison Seyler as Vice President of Sales to Drive Growth...

SurgePays Appoints Mark Garner as Executive Vice President

SurgePays Appoints Mark Garner as Executive Vice President SurgePays Appoints Mark Garner as Executive Vice President PR Newswire BARTLETT, Tenn., Jan. 24, 2025 Industry veteran brings nearly three...

SurgePays' ClearLine Marketing Platform Integrates with Clover Point of Sale System

SurgePays' ClearLine Marketing Platform Integrates with Clover Point of Sale System SurgePays' ClearLine Marketing Platform Integrates with Clover Point of Sale System PR Newswire BARTLETT, Tenn...

This Week’s Hottest Themes: Biotech (RFK Jr. Meddling), Space (Trump's Space Force),&nbsp; AI (The Theme of the Year)&nbsp;WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in sectors actively drawing capital. This targeted approach, combined with real-time news surveillance, helps us uncover stocks poised for powerful multi-day or multi-month moves—often long before Wall Street analysts catch on.Here's a list of today's most important names:1. Cassava Sciences (NASDAQ: SAVA)Background: Cassava Sciences is a clinical-stage biotechnology company focused on Alzheimer’s disease. Its investigational drug, Simufilam, has been central to its research efforts.The News: Cassava's stock took a dramatic plunge after disappointing Phase 3 trial results for Simufilam, followed by a social media storm triggered by Martin Shkreli’s scathing critique of the drug’s efficacy. Shkreli, calling Simufilam’s mechanism “implausible,” encouraged short-sellers, predicting a sharp decline in the stock. The failure of the trial and Shkreli’s influence sent shares tumbling by more than 85%, from nearly $30 per share to under $5.What It Means: This setback emphasizes the significant risks in Alzheimer's drug development. With most Alzheimer’s trials failing, investors now question the credibility of Cassava’s lead drug. While the company still has resources to pivot, the stock’s credibility has been deeply shaken, and the road ahead is uncertain.Stock Reaction: Yesterday the stock opened at $30 but closed near $5, reflecting a swift and steep sell-off. The market’s reaction shows how quickly investor sentiment can turn negative on biotech stocks, particularly in high-risk, high-reward sectors like Alzheimer’s treatment.&nbsp;2. Poseida Therapeutics (NASDAQ: PSTX)Background: Poseida is a biopharmaceutical company specializing in gene therapies, particularly CAR-T treatments for cancer.The News: Poseida announced a significant partnership with Roche, securing $110 million upfront and up to $1 billion in potential milestones. This deal is aimed at accelerating Poseida's CAR-T therapies and other cell and gene therapy technologies.What It Means: This collaboration is a major validation for Poseida’s technology, especially in the competitive CAR-T space, which has attracted attention due to its potential to treat cancers. The cash infusion from Roche is expected to fuel further research and development.Stock Reaction: Poseida opened at $9.26, up over 200%, rising slightly to close at $9.38. The market responded favorably to the news, viewing the Roche deal as a solid indication of Poseida’s future potential in the cancer treatment landscape.&nbsp;3. KULR Technology Group (NYSE: KULR)Background: KULR specializes in thermal management technologies for energy storage and aerospace.The News: KULR Technology Group has received a U.S. Navy contract to develop its Internal Short Circuit (ISC) technology to operate at higher temperatures. This upgrade is important for both military and commercial applications, especially in aviation where it aligns with safety standards. The ISC devices, originally developed with NASA and NREL, simulate controlled thermal runaway in lithium-ion cells for more accurate and safer testing of battery behavior in extreme conditions.What It Means: The Navy contract could serve as a major stepping stone for KULR, providing the company with exposure to one of the most demanding industries for thermal solutions. This deal not only enhances KULR’s credibility but may also open doors for similar partnerships in the aerospace and defense sectors.Stock Reaction: The stock opened at $0.80 and climbed another 20% reaching $0.96 by mid-morning on volume that is 1,000%+ higher than average.&nbsp;4. POET Technologies (NASDAQ: POET)Background: POET is a leader in photonics technology, designing advanced semiconductor solutions aimed at AI, telecommunications, and data storage.The News: POET Technologies (NASDAQ: POET) is ramping up production of its optical engines to meet the increasing demand from AI applications. A recent report highlighted that while many companies in the UK are adopting AI, few have integrated it into their manufacturing processes, which could hinder innovation and productivity. The report suggests that government support and regulations could help accelerate AI adoption in industries.What It Means: As AI applications continue to expand, POET’s new platform could be a game-changer. The optical interposer aims to address the bottlenecks in data processing by enabling faster, more efficient communication between chips, which is crucial for AI and big data.Stock Reaction: POET opened at $4.38 and rose to $5.35 (up 22%) by mid-day on volume 3x higher than average.&nbsp;5. SurgePays (NASDAQ: SURG)Background: SurgePays provides financial services and prepaid wireless solutions for underserved markets.The News:&nbsp;SurgePays (SURG) has integrated its ClearLine marketing platform with PAX smart payment terminals, allowing merchants to deliver real-time promotions and offers during transactions. This integration leverages existing hardware to enhance customer engagement and streamline marketing efforts, helping retailers boost loyalty and sales. SurgePays aims to scale its retail presence by utilizing PAX's wide reach in the payment terminal industry.What It Means: SurgePays continues to capitalize on the significant need for affordable financial services and wireless solutions in underserved communities. This strong performance suggests the company’s business model is scaling effectively, positioning it well for future growth.Stock Reaction: SurgePays opened at $2.00 and surged to $2.20, up 10%, trading average volume.&nbsp;6. TOYO Ventures Holdings (NASDAQ: TOYO)Background: TOYO Co., Ltd. is a solar solutions company focused on becoming a full-service provider in the global market. It integrates all stages of the solar power supply chain, including wafer and silicon production, solar cell manufacturing, and photovoltaic module production. TOYO is positioned to produce high-quality solar cells at a competitive scale and cost.The News: TOYO Co., Ltd (Nasdaq: TOYO) has secured a $150 million contract to supply high-efficiency solar cells to a major solar module manufacturer. The agreement will support solar module production in India and the U.S., leveraging TOYO’s advanced manufacturing capabilities in Vietnam and Ethiopia. This contract highlights the company's commitment to sustainable energy and the global shift towards renewable resources.What It Means: The $150 million contract is a major win for TOYO Co., Ltd, solidifying its role as a key player in the solar energy sector. It highlights the company’s advanced manufacturing capabilities and global reach, particularly in India and the U.S. For the market, the deal signals continued growth in the solar industry, boosting confidence in renewable energy technologies and potentially attracting more investment. TOYO’s expanded presence in key markets could strengthen its competitive position as demand for efficient solar cells rises..Stock Reaction: Shares opened at $5.56, up 39% to retrace to $4.50 by mid-morning and closing at $5.41 on eye-poping 1,500x average volume.&nbsp;&nbsp;7. Anavex Life Sciences (NASDAQ: AVXL)Background:&nbsp;Anavex Life Sciences develops treatments for neurodegenerative disorders like Alzheimer's and Parkinson's. Its lead drug, ANAVEX®2-73, has shown positive results in Phase 2 trials, while the company is also developing ANAVEX®3-71 for Alzheimer's.The News:Anavex Life Sciences has submitted a Marketing Authorization Application (MAA) for its drug, blarcamesine (ANAVEX®2-73), to the European Medicines Agency (EMA) for the treatment of Alzheimer’s disease. Blarcamesine, an orally administered small molecule, showed significant clinical improvement in patients over 48 weeks, with better efficacy than approved therapies and a slower rate of neurodegeneration in early Alzheimer's patients. Its safety profile eliminates the need for routine MRI monitoring, making it a promising treatment option.What It Means:&nbsp;The MAA submission for blarcamesine to the EMA is a positive development for Anavex Life Sciences, potentially boosting its stock if approved. If successful, blarcamesine could open new revenue streams and strengthen investor confidence. For the broader market, this signals progress in Alzheimer’s treatment, potentially drawing more investment into biotech, especially in neurodegenerative diseases.Stock Reaction: Anavex opened at $10.30 up 10% from Monday's close, but cratered almost 20% from that high by mid-afternoon closing nearly flat from the previous day's close on slightly higher than average volume.&nbsp;&nbsp;Be The First to Know:&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/newsletter-sign-up/">Our email list eats first! Get exclusive alerts on explosive stock picks like AST&nbsp;SpaceMobile (NASDAQ: ASTS) which shot up&nbsp;+533% after our profile. Get our email signals based on our proprietary 5-indicator system before any of our other platforms by clicking here.</a>&nbsp;&nbsp;<hr>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/WealthyVC">Follow us on Twitter</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.instagram.com/wealthyventurecapital/">Follow us on Instagram</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/TheWealthyVentureCapitalist/?locale=zh_CN">Follow us on Facebook</a><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/groups/WealthyVC">Join the Discussion in the WVC Facebook Investor Group</a>Have a Stock Tip or New&nbsp; Story Suggestion? Email us at Invest@WealthyVC.comDisclaimer: Wealthy VC does not hold a position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.This article was written by an independent contributor and does not reflect the views of Stocktwits. It has not been edited for content. The information provided here is intended solely for informational and educational purposes, and should not be interpreted as investment advice. Stocktwits does not endorse the purchase or sale of any security nor does it make any claims about the financial status of any company.

News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

SurgePays Integrates its ClearLine Marketing Platform with PAX Smart Payment Terminals

SurgePays Integrates its ClearLine Marketing Platform with PAX Smart Payment Terminals SurgePays Integrates its ClearLine Marketing Platform with PAX Smart Payment Terminals PR Newswire BARTLETT...

SurgePays, Inc. operates as a technology-driven company, which focuses on building a supply chain software platform as an alternative to traditional wholesale supply chain distribution models. It offers goods and services direct to convenience stores, bodegas, minimarts, tiendas and other corner stores, providing goods and services primarily to the underbanked community. The company was founded on August 18, 2006 and is headquartered in Bartlett, TN.

Surgepays Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$2.73
Prev Close	$2.73
Open	$2.71
Dividend Yield	0.00%
50-Day Moving Average	$2.72
Beta	0.86
Avg. Volume	74,679.90
PE Ratio	-1.11

52-Week High	$3.47
52-Week Low	$1.05
Market Capitalization	$55.78M
EPS (Annual)	-$2.39
Price to Book	464.29
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

SURG
Surgepays Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SURG News

SURGSurgepays Inc